切换至 "中华医学电子期刊资源库"

中华消化病与影像杂志(电子版) ›› 2024, Vol. 14 ›› Issue (04) : 378 -381. doi: 10.3877/cma.j.issn.2095-2015.2024.04.018

综述

直肠癌神经浸润的影像评估进展
何蓉1, 张义2, 李盼盼3, 宋歌声1, 李爱银1, 王艺1,()   
  1. 1. 250014 济南,山东第一医科大学第一附属医院(山东省千佛山医院)放射科
    2. 250200 济南市章丘区第二人民医院CT室
    3. 250013 济南,山东第一医科大学附属中心医院医学影像中心
  • 收稿日期:2024-01-30 出版日期:2024-08-01
  • 通信作者: 王艺
  • 基金资助:
    山东第一医科大学(山东省医学科学院)青年科学基金培育资助计划项目(202201-080)

Progress of imaging assessment of perineural invasion in rectal cancer

Rong He1, Yi Zhang2, Panpan Li3, Gesheng Song1, Aiyin Li1, Yi Wang1,()   

  1. 1. Department of Radiology, the First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital), Jinan 250014, China
    2. CT Room, Zhangqiu District Second People's Hospital, Jinan 250200, China
    3. Medical Imaging Centre, the Central Hospital Affiliated to Shandong First Medical University, Jinan 250013, China
  • Received:2024-01-30 Published:2024-08-01
  • Corresponding author: Yi Wang
引用本文:

何蓉, 张义, 李盼盼, 宋歌声, 李爱银, 王艺. 直肠癌神经浸润的影像评估进展[J]. 中华消化病与影像杂志(电子版), 2024, 14(04): 378-381.

Rong He, Yi Zhang, Panpan Li, Gesheng Song, Aiyin Li, Yi Wang. Progress of imaging assessment of perineural invasion in rectal cancer[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(04): 378-381.

直肠癌是严重影响人类生存、生活质量的常见消化道恶性肿瘤之一,T1~2N0直肠癌治疗是以全直肠系膜切除术为主要手段,T3~4或N+患者推荐新辅助治疗。神经浸润(PNI)指肿瘤接近神经并包绕至少33%神经周径或者肿瘤细胞穿透神经鞘三层中的任意一层。PNI是直肠癌重要的生物学特征和预后影响因素,目前只能通过术后病理诊断。不能手术的晚期直肠癌患者在新辅助化疗前,若能通过无创影像手段获取直肠癌PNI状态,将进一步完善患者的个性化诊疗并影响预后。本文对直肠癌PNI的影像学评估的研究进展进行综述。

Rectal cancer is one of the common gastrointestinal malignant tumors that seriously affects human survival and quality of life. Total mesorectal excision (TME) is the main method for the treatment of T1-2N0 rectal cancer, and neoadjuvant therapy is recommended for T3-4 or N+ patients. Perineural invasion (PNI) refers to the tumor approaching the nerve and wrapping at least 33% of the nerve circumference or the tumor cells penetrating any of the three layers of the nerve sheath. PNI is an important biological feature and prognostic factor of rectal cancer, and its diagnosis can only be confirmed by postoperative pathology. Before neoadjuvant therapy for advanced rectal cancer patients who cannot be operated, if the PNI status of rectal cancer can be obtained by noninvasive imaging means, it will further improve the personalized diagnosis and influence the prognosis of patients. This article reviews the research progress of imaging evaluation of PNI in rectal cancer.

[1]
陈宏达, 代敏. 中国结直肠癌预防和控制的思考[J]. 中华流行病学杂志, 2020, 41(10): 1627-1632.
[2]
Galon J, Mlecnik B, Bindea G, et al. Towards the introduction of the 'Immunoscore’ in the classification of malignant tumours[J]. J Pathol, 2014, 232(2): 199-209.
[3]
Nagtegaal ID, Quirke P, Schmoll HJ. Has the new TNM classification for colorectal cancer improved care[J]. Nat Rev Clin Oncol, 2011, 9(2): 119-123.
[4]
Benson AB, Venook AP, Al-Hawary MM, et al. Rectal Cancer, Version 2. 2022, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2022, 20(10): 1139-1167.
[5]
Kim YI, Kim CW, Kim JH, et al. Clinical Implication of Perineural and Lymphovascular Invasion in Rectal Cancer Patients Who Underwent Surgery After Preoperative Chemoradiotherapy[J]. Dis Colon Rectum, 2022, 65(11): 1325-1334.
[6]
Sung SY, Kim SH, Jang HS, et al. Pathologic Implications of Radial Resection Margin and Perineural Invasion to Adjuvant Chemotherapy after Preoperative Chemoradiotherapy and Surgery for Rectal Cancer: A Multi-Institutional and Case-Matched Control Study[J]. Cancers(Basel), 2022, 14(17): 4112.
[7]
Batsakis JG. Nerves and neurotropic carcinomas[J]. Ann Otol Rhinol Laryngol, 1985, 94(4 Pt 1): 426-427.
[8]
Veness MJ. Perineural spread in head and neck skin cancer[J]. Australas J Dermatol, 2000, 41(2): 117-119.
[9]
Liebig C, Ayala G, Wilks JA, et al. Perineural invasion in cancer: a review of the literature[J]. Cancer, 2009, 115(15): 3379-3391.
[10]
Stojkovic Lalosevic M, Milovanovic T, Micev M, et al. Perineural invasion as a prognostic factor in patients with stage I-III rectal cancer-5-year follow up[J]. World J Gastrointest Oncol, 2020, 12(5): 592-600.
[11]
Song JH, Yu M, Kang KM, et al. Significance of perineural and lymphovascular invasion in locally advanced rectal cancer treated by preoperative chemoradiotherapy and radical surgery: Can perineural invasion be an indication of adjuvant chemotherapy?[J]. Radiother Oncol, 2019, 133: 125-131.
[12]
Kim CH, Yeom SS, Lee SY, et al. Prognostic impact of perineural invasion in rectal cancer after neoadjuvant chemoradiotherapy[J]. World J Surg, 2019, 43(1): 260-272.
[13]
Vergara-Fernandez O, Navarro-Navarro A, Rangel-Ríos HA, et al. Oncological implications of lymph nodes retrieval and perineural invasion in colorectal cancer: outcomes from a referral center[J]. Rev Invest Clin, 2018, 70(6): 291-300.
[14]
Hu G, Li L, Hu K. Clinical implications of perineural invasion in patients with colorectal cancer[J]. Medicine(Baltimore), 2020, 99: 17(e19860).
[15]
Song J, Yin H, Zhu Y, et al. Identification of Predictive Factors for Lymph Node Metastasis in pT1 Stage Colorectal Cancer Patients: A Retrospective Analysis Based on the Population Database[J]. Pathol Oncol Res, 2022, 28: 1610191.
[16]
Xu Y, Chen Y, Long C, et al. Preoperative Predictors of Lymph Node Metastasis in Colon Cancer[J]. Front Oncol, 2021, 11: 667477.
[17]
张龙, 郭源, 杜正华, 等. 结直肠癌神经侵犯风险因素及预后分析[J]. 右江医学, 2020, 48(1): 57-61.
[18]
Kim S, Huh JW, Lee WY, et al. Lymphovascular invasion, perineural invasion, and tumor budding are prognostic factors for stage I colon cancer recurrence[J]. Int J Colorectal Dis, 2020, 35(5): 881-885.
[19]
Nikberg M, Chabok A, Letocha H, et al. Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry[J]. Acta Oncol, 2016, 55(12): 1418-1424.
[20]
Chi AC, Katabi N, Chen HS, et al. Interobserver Variation Among Pathologists in Evaluating Perineural Invasion for Oral Squamous Cell Carcinoma[J]. Head Neck Pathol, 2016, 10(4): 451-464.
[21]
Yan F, Cheng YL, Katabi N, et al. Interobserver variation in evaluating perineural invasion for oral squamous cell carcinoma: phase 2 survey study[J]. Head Neck Pathol, 2021, 15(3): 935-944.
[22]
Bellis D, Marci V, Monga G. Light microscopic and immunohistochemical evaluation of vascular and neural invasion in colorectal cancer[J]. Pathol Res Pract, 1993, 189(4): 443-447.
[23]
Alves AP, Paula DS, Lima LV, et al. Is immunohistochemistry more sensitive than hematoxylin-eosin staining for identifying perineural or lymphovascular invasion in oral squamous cell carcinoma? A systematic review and meta-analysis[J]. Med Oral Patol Oral Cir Bucal, 2022, 27(3): e238-e247.
[24]
陈东, 陈海涛, 李支尧, 等. 直肠腔内三维超声和MRI对中下段直肠癌壁外血管侵犯程度的评估效果[J]. 吉林大学学报(医学版), 2021, 47(1): 203-209.
[25]
阮成伟. 螺旋CT与磁共振成像(MRI)在直肠癌术前分期诊断中的应用价值分析[J]. 实用中西医结合临床, 2021, 21(6): 119-120.
[26]
柴亚欣, 李振玉, 牛永超, 等. 高分辨率MRI在直肠癌术前TN分期及环周切缘评估中的应用价值[J]. 实用放射学杂志, 2021, 37(11): 1830-1833.
[27]
熊健, 郑历明, 余汉城, 等. 3.0T高分辨率MRI诊断直肠癌盆腔侧方淋巴结转移的临床价值[J]. 实用放射学杂志, 2022, 38(1): 60-63.
[28]
中华医学会放射学分会, 中国医师协会放射医师分会, 安徽省影像临床医学研究中心. 能量CT临床应用中国专家共识[J]. 中华放射学杂志, 2022, 56(5): 476-487.
[29]
黄豆豆, 陈峻帆, 韦鑫, 等. 双能CT定量参数联合CT特征预测结直肠腺癌周围神经浸润[J]. 中国医学影像技术, 2023, 39(12): 1827-1832.
[30]
Lu W, Tan X, Zhong Y, et al. Spectral CT in the evaluation of perineural invasion status in rectal cancer[J]. Jpn J Radiol, 2024.
[31]
Liu J, Sun L, Zhao X, et al. Development and validation of a combined nomogram for predicting perineural invasion status in rectal cancer via computed tomography-based radiomics[J]. J Cancer Res Ther, 2023, 19(6): 1552-1559.
[32]
中华人民共和国国家卫生健康委员会. 中国结直肠癌诊疗规范(2020年版)[J].中华外科杂志, 2020, 58(8): 561-585.
[33]
Ma J, Guo D, Miao W, et al. The value of 18F-FDG PET/CT-based radiomics in predicting perineural invasion and outcome in non-metastatic colorectal cancer[J]. Abdom Radiol(NY), 2022, 47(4): 1244-1254.
[34]
Chen J, Chen Y, Zheng D, et al. Pretreatment MR-based radiomics nomogram as potential imaging biomarker for individualized assessment of perineural invasion status in rectal cancer[J]. Abdom Radiol(NY), 2021, 46(3): 847-857.
[35]
Yang YS, Qiu YJ, Zheng GH, et al. High resolution MRI-based radiomic nomogram in predicting perineural invasion in rectal cancer[J]. Cancer Imaging, 2021, 21(1): 40.
[36]
Zhang K, Ren Y, Xu S, et al. A clinical‐radiomics model incorporating T2‐weighted and diffusion‐weighted magnetic resonance images predicts the existence of lymphovascular invasion/perineural invasion in patients with colorectal cancer[J]. Med Phys, 2021, 48(9): 4872-4882.
[37]
Zhang Y, Peng J, Liu J, et al. Preoperative Prediction of Perineural Invasion Status of Rectal Cancer Based on Radiomics Nomogram of Multiparametric Magnetic Resonance Imaging[J]. Front Oncol, 2022, 12: 828904.
[38]
Li W, Jiang Z, Guan Y, et al. Whole-lesion Apparent Diffusion Coefficient First-and Second-Order Texture Features for the Characterization of Rectal Cancer Pathological Factors[J]. J Comput Assist Tomogr, 2018, 42(4): 642-647.
[39]
Guo Y, Wang Q, Guo Y, et al. Preoperative prediction of perineural invasion with multi-modality radiomics in rectal cancer[J]. Sci Rep, 2021, 11(1): 9429.
[40]
Gourtsoyianni S, Doumou G, Prezzi D, et al. Primary rectal cancer: repeatability of global and local-regional MR imaging texture features[J]. Radiology, 2017, 284(2): 552-561.
[41]
Wan L, Peng W, Zou S, et al. Predicting perineural invasion using histogram analysis of zoomed EPI diffusion-weighted imaging in rectal cancer[J]. Abdom Radiol(NY), 2022, 47(10): 3353-3363.
[42]
Yeo DM, Oh SN, Choi MH, et al. Histogram analysis of perfusion parameters from dynamic contrast-enhanced MR imaging with tumor characteristics and therapeutic response in locally advanced rectal cancer[J]. Biomed Res Int, 2018, 2018: 3724393.
[43]
Rutman AM, Kuo MD. Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging[J]. Eur J Radiol, 2009, 70(2): 232-241.
[1] 高旭, 李若凡, 孙立新, 刘佐军, 田广健. Miles手术中预置腹膜前补片预防造口旁疝的效果及安全性[J]. 中华疝和腹壁外科杂志(电子版), 2024, 18(03): 266-272.
[2] 刘怡君, 李来元, 徐世赟, 毕亮, 姜蕾, 鲁中祥, 张加乘, 杨熊飞. 一例骶前囊肿合并低位直肠癌患者的诊治[J]. 中华结直肠疾病电子杂志, 2024, 13(03): 253-255.
[3] 张金珠, 梅世文, 孙金峰, 胡刚, 邱文龙, 李国利, 汪欣, 王锡山, 汤坚强. 原发结直肠癌超系膜切除术后患者的生存危险因素分析[J]. 中华结直肠疾病电子杂志, 2024, 13(03): 197-204.
[4] 吴浩凡, 刘元豪, 张锋敏, 张现中, 朱金浩, 黄嘉莹, 刘忠臣, 丁良福, 庄成乐. 基于术前MRI的盆底解剖参数对超低位直肠癌精准功能保肛手术时间的影响[J]. 中华结直肠疾病电子杂志, 2024, 13(03): 209-216.
[5] 刘腾, 刘萍, 仁永平, 吕琼, 吕倩婷. 腹腔镜超低位直肠癌适形保肛手术的研究进展[J]. 中华结直肠疾病电子杂志, 2024, 13(02): 141-147.
[6] 顾纪明, 蒋晖, 金留根, 钱程佳, 陈柏, 谢立飞. 腹腔镜辅助结肠次全切除术治疗同时性多原发结直肠癌的应用体会[J]. 中华结直肠疾病电子杂志, 2024, 13(02): 153-157.
[7] 马虹宇, 陈元武, 张明明, 岳向勇, 檀碧波. 平胃散加味联合毫火针对直肠癌患者化学治疗致胃肠道反应的疗效[J]. 中华消化病与影像杂志(电子版), 2024, 14(04): 297-300.
[8] 高静, 夏婷婷. 血清乳酸脱氢酶、中性粒细胞/淋巴细胞比值、血浆纤维蛋白原/前白蛋白比值对晚期结直肠癌患者姑息化疗效果与不良反应的评价[J]. 中华消化病与影像杂志(电子版), 2024, 14(03): 203-207.
[9] 孙伟, 刘敬峰, 陈晨, 杨磊. 奥沙利铂联合卡培他滨新辅助化疗治疗局部进展期低位直肠癌的疗效及影响因素[J]. 中华消化病与影像杂志(电子版), 2024, 14(03): 208-212.
[10] 朱菡, 卓士超, 吴迪, 朱雅楠, 韩佳欣. 术前血浆纤维蛋白原、血脂水平及MMR表达与结直肠癌病理特点及预后的相关性[J]. 中华消化病与影像杂志(电子版), 2024, 14(02): 141-145.
[11] 焦莉莉, 周芊池, 凌梦芸, 魏红玲, 徐缨. 血清SAA、CA19-9结合超声内镜对结直肠癌术前分期的诊断价值[J]. 中华消化病与影像杂志(电子版), 2024, 14(02): 146-150.
[12] 张朋伟, 杨朝凤, 李杨. 结直肠癌肝转移介入治疗的研究进展[J]. 中华消化病与影像杂志(电子版), 2024, 14(02): 177-182.
[13] 蒲丹, 龙煊, 周玉龙, 李甘霖. 血清外泌体miR-224对结直肠癌肝转移患者射频消融治疗后复发的预测价值[J]. 中华消化病与影像杂志(电子版), 2024, 14(01): 45-52.
[14] 黄霓, 张仕勇, 兰茜琳, 周奕, 明兵. 双源CT与MRI在结直肠癌术前分期中的临床价值分析[J]. 中华消化病与影像杂志(电子版), 2024, 14(01): 57-61.
[15] 栗慧慧, 林香春. 早发结直肠癌的临床特征及危险因素分析[J]. 中华临床医师杂志(电子版), 2024, 18(02): 195-200.
阅读次数
全文


摘要